Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study

Abstract Background Thromboembolism has been reported as a consequence of severe COVID-19. Although warfarin is a commonly used anticoagulant, it acts by antagonising vitamin K, which is low in patients with severe COVID-19. To date, the clinical evidence on the impact of regular use of warfarin on...

Popoln opis

Bibliografske podrobnosti

Principais autores:	The OpenSAFELY Collaborative, Angel Y. S. Wong, Laurie A. Tomlinson, Jeremy P. Brown, William Elson, Alex J. Walker, Anna Schultze, Caroline E. Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher T. Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J. Curtis, Amir Mehrkar, Jonathan Cockburn, Helen I. McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M. Eggo, Stephen J. W. Evans, Liam Smeeth, Ben Goldacre, Ian J. Douglas
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-10-01
Serija:	Journal of Hematology & Oncology
Teme:	Warfarin Direct oral anticoagulants COVID-19
Online dostop:	https://doi.org/10.1186/s13045-021-01185-0
Oznake:	Označite Brez oznak, prvi označite!